Updates

Paysafe - Beats forecasts again

July 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Paysafe has developed a happy knack for beating forecasts and so it proved again with its AGM revealing full year revenue is expected to be US$950m-US$970m, ahead of a forecasted US$911m. Similarly EBITDA is expected to be between US$270m-US$276m vs consensus of US$260m.Integration of Skrill is on track for completion in Q3 ‘16 with the final update expected with H1 ’16 results and synergy savings are likely to be as before.H1 results are due on 10 August and with net debt falling rapidly further attractive acquisitions are likely.Tipped at a rights issue adjusted 200p in November ’13 and again at 242p in February ‘15, the shares have gained 102% but we expect more to come. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Marstons

Polypipe

Paysafe - Bid approach (September 2017)

Paysafe (July 2017)

Paysafe - Re-rating ahead of more acquisitions (May 2017)

Paysafe - Beats expectations again (February 2017)

Paysafe - Rating is depressed for no good reason (January 2017)

Paysafe - Beats expectations again (October 2016)

Paysafe - Shares hit a new high (May 2016)

Paysafe - Barclays lifts price target to 560p (February 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X